StockData
Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc. (AGIO) stock

AGIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/308% above fair value
$29.68−0.21 (-0.70%)

Close on Nov 18, 2026Market cap $1.77BP/E –Yield –

Agios Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Agios Pharmaceuticals's market cap was $1.96B on Nov 11, 2026, against $1.70B a year earlier. Over the last 5 years it ranged from $1.07B to $3.39B, with a median of $1.70B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.96B+23.3%
2025Dec 31, 2025$1.59B-15.3%
2024Dec 31, 2024$1.87B+50.6%
2023Dec 29, 2023$1.24B-19.3%
2022Dec 30, 2022$1.54B-14.3%
2021Dec 31, 2021$1.80B-40.0%
2020Dec 31, 2020$3.00B+6.6%
2019Dec 31, 2019$2.81B+4.8%
2018Dec 31, 2018$2.68B-3.5%
2017Dec 29, 2017$2.78B+58.5%
2016Dec 30, 2016$1.75B-28.2%
2015Dec 31, 2015$2.44B-37.1%
2014Dec 31, 2014$3.88B+421.5%
2013Dec 31, 2013$744.23M–

More Agios Pharmaceuticals figures

See a number that looks wrong?